✦ LIBER ✦

Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival

✍ Scribed by Dean, R; Masci, P; Pohlman, B; Andresen, S; Serafino, S; Sobecks, R; Kuczkowski, E; Curtis, J; Maciejewski, J; Rybicki, L

Book ID: 110014815
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 130 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour infiltrating plasmacytoid dendrit

Tumour infiltrating plasmacytoid dendritic cells in B cell post-transplant lymphoproliferative disorders, human immunodeficiency virus-associated B cell lymphomas and immune competent diffuse large B cell lymphomas

✍ Hazem A H Ibrahim; Lia Menasce; Sabine Pomplun; Margaret Burke; Mark Bower; Kikk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Prognostic impact of pre-transplantation

Prognostic impact of pre-transplantation computed tomography and67gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation

✍ Ignacio G. Escobar; Pilar T. Alonso; Dolores C. Barrigon; Jose A. Perez-Simon; M 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 281 KB

LACE-conditioned autologous stem cell tr

LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre

✍ Jiří Pavlů; Holger W. Auner; Sarah Ellis; Richard M. Szydlo; Chrissy Giles; Alej 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a recognized treatment option for patients with relapsed diffuse large B-cell lymphoma. We have analysed 51 patients who underwent ASCT after LACE (lomustine (CCNU), cytarabine (Ara-C), cyclophosphamide, etoposide) con

Disease staging with positron emission t

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation

✍ Amin M. Alousi; Rima M. Saliba; Grace-Julia Okoroji; Homer A. Macapinlac; Chitra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Effect of the dose per body weight of co

Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma

✍ Luciano J. Costa; Ivana N. Micallef; David J. Inwards; Patrick B. Johnston; Luis 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

The non-relapse mortality rate for patie

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls

✍ Brian T. Hill; Lisa Rybicki; Brian J. Bolwell; Stephen Smith; Robert Dean; Matt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB